A 505(b)(2) product is an improved or altered version or a new use application for a previously FDA-approved drug. This unique regulatory pathway, available only for marketing approval in the US, offers an attractive pathway to cheaper and faster new drug development, particularly to a manufacturer with experience in developing generic products.
Webinar On - Improved Generic Drugs via the 505(b)(2) Regulatory Pathway: FDA Approval Made Easy
19 February 2014, Mississauga, Canada
Introduction
Venue
Online
Online, 5939 Candlebrook Ct,, Ontario, Mississauga, L5V 2V5, Canada
Useful links
Contact information
Related events
8th International Conference on Nanomaterials Science and Mechanical Engineering
7 July 2026 08:00 - 10 July 2026 18:00, Aveiro, Portugal
The 59th Annual International Meeting of the ESR Spectroscopy Group of the 番茄社区 of Chemistry
13 April 2026 15:00 - 16 April 2026 23:00, Colchester, United Kingdom
6th International Conference on Emerging Advanced Nanomaterials
16 November 2026 08:00 - 20 November 2026 18:00, Newcastle, Australia
Chemical Biology meets Drug Discovery
14 September 2026 09:30 - 15 September 2026 16:30, Cambridge, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
